- Poster presentation
- Open Access
Targeted testing for DNAI1 hot spot-mutation utilizing immunofluorescence microscopy findings
© Szczepaniak et al; licensee BioMed Central Ltd. 2012
- Published: 16 November 2012
- Immunofluorescence Microscopy
- Primary Cilium
- Restriction Enzyme Digestion
- Respiratory Epithelium
- DNAI1 Gene
Primary ciliary dyskinesia (PCD) is a rare (prevalence 1/20,000) genetic disease affecting motile cilia in the respiratory epithelium, spermatozoid flagella and primary cilia in the embryonic node. The most frequent (~60-70%) structural defect identified by TEM in the cilia of PCD patients are abnormal dynein arms. Several genes can cause PCD, but the majority of mutations were found in DNAH5 and DNAI1 genes (respectively ~28% and 4-10% of all cases), which encode heavy and intermediate chains of the outer dynein arms (ODAs), respectively. Mutations in both genes account collectively for almost 40% of PCD cases [Olbrich et al. 2002, Hornef et al. 2006, Zariwala et al. 2006, Zietkiewicz et al. 2010]. The hot-spot mutation in the DNAI1 gene appears in intron 1, with the frequency of the most popular mutation (IVS1+2_3insT, causes aberrant splicing) around 55% of all DNAI1 mutations. We have previously shown in a few PCD cases that proximal type-1 ODA complexes can be at least partially assembled in DNAI1– mutant cilia [Fliegauf et al. 2005]. We analysed the frequency of this hot spot mutation among 51 patients, in which immunofluorescence has identified abnormal ODA staining (proximal presence of DNAH5). The prevalence of the mutation in intron 1 of DNAI1 gene will be confirmed by PCR and restriction enzyme digestion. In addition, we analyzed respiratory cilia for the inner dynein arm component DNALI1 localization, which we expect not to be altered in DNAI1 mutant cilia, contrasting the findings present in KTU- mutant cilia.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.